KR0138248B1 - The oral cavity hygienic compositions - Google Patents
The oral cavity hygienic compositionsInfo
- Publication number
- KR0138248B1 KR0138248B1 KR1019920018403A KR920018403A KR0138248B1 KR 0138248 B1 KR0138248 B1 KR 0138248B1 KR 1019920018403 A KR1019920018403 A KR 1019920018403A KR 920018403 A KR920018403 A KR 920018403A KR 0138248 B1 KR0138248 B1 KR 0138248B1
- Authority
- KR
- South Korea
- Prior art keywords
- composition
- extract
- oral hygiene
- weight
- toothpaste
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Birds (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
본 발명은 금초(Yarrow), 마로니에(Horse chestnut) 식물 추출물을 1종 또는 2종 함유하는 구강위생 증진용 조성물에 관한 것이다.The present invention relates to a composition for enhancing oral hygiene, containing one or two of Yarrow, Horse chestnut (Horse chestnut) plant extract.
Description
본 발명은 치주질환 예방, 치료 및 충치예방에 효과가 우수한 구강위생 증진용 조성물에 관한 것으로서, 더욱 상세하게는 약용식물로부터 추출한 식물추출물을 구강조성물에 적용함으로써 치주질환 예방, 치료 및 충치에방 효과를 증진시킨 구강위생 증진용 조성물에 관한 것이다.The present invention relates to an oral hygiene-promoting composition excellent in preventing, treating and preventing tooth decay, and more particularly, by applying a plant extract extracted from a medicinal plant to an oral composition, to prevent and treat periodontal disease. It relates to a composition for enhancing oral hygiene.
구강 위생을 유지하기 위한 한 방법으로서 치솔과 치약을 사용하여 양치하는 것이 가장 보편적이다. 치약을 사용하는 이유는 연마제와 세제를 사용하여 치솔질하므로서 기계적인 치태제거를 쉽게하고 치면을 활택하게 하고, 입안을 더욱 깨끗하고 상쾌하게 하여 이를 닦는 것 자체를 즐겁게 하는 것이다. 그러나 이러한 치태제거 방법에 의해서 충분한 구강위생의 유지와 치아우식증 및 치주질환의 예방 효과를 얻기는 쉽지 않아서 많은 사람들이 치은 염증을 가지고 있으며 연령이 증가함에 따라 치주질환의 발생율 및 그로 인한 치아 상실이 증가하는 실정이다. 그리하여 충치 원인균(Streptococcus mutans)과 치주 질환의 원인균들(Actinomyces Viscosus, Bacteroides gingivalis, Rothia dentocariosa, Streptococcus mitis 등)에 대하여 살균 효과가 있는 물질들에 대한 많은 연구가 행해지고 있으며, 현재 방부제, 약용식물의 추출물, 효소, 금속염 등이 많이 알려져 있다.Brushing teeth using toothbrushes and toothpaste is the most common way to maintain oral hygiene. The reason for using toothpaste is to brush teeth with abrasives and detergents, making mechanical plaque easier, lubricating the tooth surface, and making your mouth cleaner and more refreshing. However, it is not easy to obtain sufficient maintenance of oral hygiene and prevention of dental caries and periodontal disease by this method of removing plaque, so many people have gingival inflammation and the incidence of periodontal disease and the resulting tooth loss increase with age. It is the situation. Thus, many studies have been conducted on substances having bactericidal effects against the causative bacteria of Streptococcus mutans and periodontal diseases (Actinomyces Viscosus, Bacteroides gingivalis, Rothia dentocariosa, Streptococcus mitis, etc.). , Enzymes, metal salts and the like are known a lot.
위와 같이 수천년간 민간에서 널리 사용되어져 왔으며, 충치원인균 및 치주질환 원인균등에 효과가 있는 것으로 카모밀레(Chamomile), 몰약(Myrrh), 라타니(Rhatany), 세이지(Sage) 에치네시아(Echinacea)등의 추출물(S. de Rysky; Journal of Clinical Dentistry Vol.I, Supplement A. A22-24, 1988), 생귀나리아(Sanguinaria) 추출물(미합중국 특허 4,689,216호), 홈(Hops) 추출물(일본국 공개 특허 공보 소 62-138,420호), 세이지(Sage) 및 미질향(Rosemary) 등의 추출물(일본국 공개 특허 공보 소 58-134,013호) 등이 알려져 있다.It has been widely used in the private sector for thousands of years, and is effective in causative agents of caries and periodontal disease, such as chamomile, myrrh, ratany, sage, echinacea, etc. (S. de Rysky; Journal of Clinical Dentistry Vol.I, Supplement A. A22-24, 1988), Sanguinaria Extract (US Pat. No. 4,689,216), Hops Extract (Japanese Laid Open Patent) Japanese Patent Application Laid-Open No. 62-138,420), extracts such as Sage and Rosemary (Japanese Laid-Open Patent Publication No. 58-134,013) and the like are known.
본 발명은 충치원인균에 의하여 야기되는 치태형성 억제작용, 항염증작용, 지혈작용, 구취제거 작용등에 효과가 우수한 30 여종의 식물 추출물을 검토하던 중 금초(Yarrow)와 마로니에(Horse Chestnut) 등의 추출물이 치태형성 억제작용, 염증 완화작용등에 효과가 우수함을 밝혀내고 본 발명을 완성하게 되었다.In the present invention, while extracting 30 kinds of plant extracts excellent in the effect of inhibiting plaque formation, anti-inflammatory, hemostatic, and bad breath caused by caries, the extract of Yarrow and Horse Chestnut, etc. The present invention has been found to be excellent in the effect of inhibiting plaque formation, reducing inflammation, and the like.
금초는 트로얀 전쟁(Trojan war Ca. 1200 B.C) 때에 그리스 영웅 아킬레스(Achilles)가 부하들의 부상으로 흐르는 피를 멈추게 하기 위해 사용한 이후로는 인기있는 민간약으로 널리 사용되어 왔으며, 특히 암, 종양, 염증, 경련성, 바이러스성, 치통, 상처 등을 치료하는데 사용해 왔다.(J.A.Duke : Handbook of Medicinal Herbs, Herbs, CRC press, 9-10, 1985).It has been widely used as a popular folk medicine since the Greek hero Achilles during the Trojan war Ca. 1200 BC was used to stop blood flowing from the injuries of his men, especially cancer, tumors and inflammation. , Cramps, viral, toothache, wounds, etc. (JADuke: Handbook of Medicinal Herbs, Herbs, CRC press, 9-10, 1985).
본 발명의 식물추출물은 수증기 증류, 극성 및 비극성 유기용매를 사용하여 제조한다. 수증기 증류추출은 짧게 절단된 약용식물을 추출기에 넣고 물을 증류시켜 수증기가추출기에 혼입되면 그 혼입된 수증기에 의해서 생약의 활성성분이 추출되게 되는데(이때 추출기의 내부온도는 약 90℃로 조정됨). 이때 추출된 추출액을 모아 여과하고 이것을 감압농축시킨후 과립상태로 만들며, 극성 및 비극성 유기용매 추출은 퍼콜레이숀법에 따라 제조하여 감압 농축시킨 후 사용한다. 유기용매로는 에칠알콜, 메탄올, 아세톤, 핵산, 벤젠, 물-에탄올 등을 사용한다.The plant extract of the present invention is prepared using steam distillation, polar and nonpolar organic solvents. Steam distillation extracts short-cut medicinal plants into an extractor, distills water into the extractor, and when the steam is incorporated into the extractor, the active ingredient of the herbal medicine is extracted (the internal temperature of the extractor is adjusted to about 90 ℃). ). At this time, the extracted extract is collected, filtered and concentrated under reduced pressure to make a granular state. Polar and nonpolar organic solvent extraction is prepared according to the percolation method and concentrated under reduced pressure. As the organic solvent, ethanol, methanol, acetone, nucleic acid, benzene, water-ethanol and the like are used.
더욱 구체적으로, 본 발명은 금초 또는 마로니에 식물추출물을 1종 또는 2종 함유하는 구강 위생증진용 조성물을 제공한다.More specifically, the present invention provides a composition for promoting oral hygiene containing one or two kinds of vinegar or horse chestnut plant extract.
본 발명의 구강위생 증진용 조성물은 식물 추출물을 단독 또는 2종 혼합하여 조성물 총중량당 0.02 내지 4.5중량%, 바람직하게는 0.05 내지 3중량% 함유하는 것이 좋다.Oral hygiene-promoting composition of the present invention is to contain a plant extract alone or two kinds are mixed 0.02 to 4.5% by weight, preferably 0.05 to 3% by weight of the total weight of the composition.
식물 추출 성분을 0.02중량% 이하로 사용할 때는 치주질환 예방, 치료 및 충치예방효과가 미약하게 되고 4.5중량% 이상 사용할 때는 추출물들의 각 성분의 특이한 맛에 의해 제품의 사용감을 저하시키게 된다.When the plant extract components are used at less than 0.02% by weight, the periodontal disease prevention, treatment and caries prevention effect is weak, and when used at more than 4.5% by weight, the unique taste of each component of the extract lowers the feeling of use of the product.
본 발명에 따른 구강위생 증진용 조성물은 구강제품인 치약, 구강청정제, 의치세정데, 츄잉껌 등의 통상적인 성분에 치주질환예방, 치료 및 충치예방효과가 우수한 약용 성분으로서 금초(Yarrow), 마로니에(Horse chestnut) 식물추출물을 단독 또는 2종 혼합시켜 제조할 수 있다.Oral hygiene-promoting composition according to the present invention is an oral product toothpaste, mouthwash, denture cleaning, chewing gum and other common ingredients as excellent medicinal ingredients excellent in preventing periodontal disease prevention, treatment and tooth decay (Yarrow), Maronier (Horse) chestnut) Plant extract can be prepared by mixing alone or two kinds.
본 발명의 타성분으로는 구강 조성물의 종류 및 사용목적에 따라 통상 사용하는 성분의 적당량을 사용하여 배합하였다. 예를들어 본 발명의 치약조성물은 통상적인 치약성분들로서 연마제, 습윤제, 결합제, 기포제, 감미제, 방부제, 약효제, 향료, PH 조정제, 증백제등을 함유할 수 있다.The other component of the present invention was formulated using an appropriate amount of the component normally used according to the kind and purpose of the oral composition. For example, the toothpaste composition of the present invention may contain abrasives, wetting agents, binders, foaming agents, sweeteners, preservatives, medicinal agents, flavoring agents, pH adjusters, brighteners and the like as conventional toothpaste components.
연마제로는 탄산칼슘, 인산일수소칼슘, 침강실리카, 함수알루미나, 실리카겔, 불용성 메타인산나트륨, 지르코늄 실리케이트 등이 있으며, 이들 연마제를 단독 혹은 2종 이상 혼합하여 20 내지 60중량%, 바람직하게는 20 내지 50중량%를 사용한다.Examples of the abrasive include calcium carbonate, calcium dihydrogen phosphate, precipitated silica, hydrous alumina, silica gel, insoluble sodium metaphosphate, zirconium silicate, and these abrasives alone or in combination of two or more thereof, 20 to 60% by weight, preferably 20 To 50% by weight.
습윤제로는 글리세린, 솔비톨액, 비결정성 솔비톨액을 단독 또는 2종이상 혼합하여 20 내지 60중량%, 바람직하게는 20 내지 50중량%를 사용한다.As the humectant, 20 to 60% by weight, preferably 20 to 50% by weight of glycerin, sorbitol solution, and amorphous sorbitol solution alone or in mixture of two or more thereof are used.
결합제로는 카라기난, 잔탄껌, 카르복시메틸 셀룰로오스 나트륨, 카르복시 비닐폴리머(상품명 카르보폴), 알긴산 나트륨 등을 단독 또는 2종이상 혼합하여 0.1 내지 3.0중량%, 바람직하게는 0.5 내지 2.0중량%를 사용한다.As the binder, 0.1 to 3.0% by weight, preferably 0.5 to 2.0% by weight of carrageenan, xanthan gum, sodium carboxymethyl cellulose, carboxy vinyl polymer (trade name Carbopol), sodium alginate, or the like may be used alone or in combination of two or more thereof. .
기포제로는 라우릴 황산나트륨, 라우릴 사르코신산 나트륨 등의 음이온 계면활성제와 소르비탄 지방산 에스테르, 폴리옥시에틸렌 경화 피마자유, 폴리옥시에틸렌 폴리옥시 프로필렌계 축합 고분자 물질 등을 단독 또는 2종이상 혼합 사용하여 0.5 내지 5중량%, 바람직하게는 0.5 내지 2.5중량%를 사용한다.As the foaming agent, anionic surfactants such as sodium lauryl sulfate and sodium lauryl sarcosinate, sorbitan fatty acid esters, polyoxyethylene-cured castor oil, polyoxyethylene polyoxypropylene-based condensed polymer materials, etc. may be used alone or in combination of two or more thereof. 0.5 to 5% by weight, preferably 0.5 to 2.5% by weight is used.
감미제는 삭카린나트륨, 아스파탐, 스테비오시드, 감초산 등을 단독 또는 2종이상 혼합하여 0.05 내지 0.5중량%를 사용하는 것이 좋다.As a sweetener, saccharin sodium, aspartame, stevioside, licorice acid, etc. may be used alone or in combination of two or more, and 0.05 to 0.5% by weight is used.
방부제로는 파라옥시 안식향산 에스텔, 안식향산, 안식향산 나트륨을 단독 또는 2종 이상 혼합 사용한다. 약효제로는 불화나트륨, 클로로헥시딘, 트라넥사민산, 알란토인류, 카프론산, 감초 엑기스, 산페논, 생귀나린 엑기스, 황백 엑기스, 카모밀레 엑기스, 라타니 엑기스, 몰약 엑기스, 세지 엑기스, 미질향 엑기스, 홉 엑기스, 에치네시아 엑기스 등을 사용한다. 향료로는 페파민트 오일, 스페아민트 오일, 멘톨, 카르본 등을 적당량 혼합사용하며, pH 조정제로는 인산, 인산나트륨, 구연산, 구연산 나트륨, 호박산, 호박산나트륨, 주석산, 주석산나트륨 등을 사용하며 적당한 pH 범위는 5 내지 8이며, 증백제로 산화티탄을 적당하기로는 0.5 내지 5중량% 사용한다.As a preservative, paraoxy benzoic acid ester, benzoic acid, and sodium benzoate are used individually or in mixture of 2 or more types. Pharmacologic agents include sodium fluoride, chlorohexidine, tranexamic acid, allantoin, capronic acid, licorice extract, sanphenone, raw guinea extract, sulfur white extract, chamomile extract, ratani extract, myrrh extract, sage extract Use incense extracts, hop extracts, and Echinacea extracts. As a fragrance, a suitable amount of peppermint oil, spearmint oil, menthol, and carbon are mixed and used as a pH adjuster. Phosphoric acid, sodium phosphate, citric acid, sodium citrate, succinic acid, sodium succinate, tartaric acid and sodium stannate are used. The range is 5 to 8, and titanium oxide is preferably 0.5 to 5% by weight as the brightener.
이하, 본 발명을 실험예 및 실시예에 의거 상세히 설명하기로 한다.Hereinafter, the present invention will be described in detail based on the experimental examples and examples.
실시예 1 : 구강 미생물에 대한 식물 추출물들의 살균력 시험Example 1 Test of Sterilization of Plant Extracts against Oral Microorganisms
식물추출물 종류Plant Extract Types
아르니카(Arnica), 자작나무(Birch), 카모밀레(Chamomile),Arnica, Birch, Chamomile,
인삼(Ginseng), 헤이플라우(Hay Flower), 헨나누트랄(Henna neutral),Ginseng, Hay Flower, Henna neutral,
미질향(Rosemary), 살비아(Sage),Rosemary, Sage,
금초(Yarrow), 마로니에(House chestnut)등Yarrow, House chestnut, etc.
시험균주Test strain
스트렙토 코카즈 뮤탄즈(Streptococcus mutans 10449, 혈청형 C)Streptococcus mutans 10449, serotype C
로티아 덴토카리오사(Rothia dentocariosa)Rothia dentocariosa
스크렙토 코카즈 미티스(Streptococcus mitis)Streptococcus mitis
악티노 마이세스 비스코서스(Actinomyces Viscocus)Actinomyces Viscocus
실험방법Experiment method
각 추출물 0.1g를 10미리리터의 BHI(Brain Heart Infusion)에 첨가한 후 1 내지 2일 배양한 균주를 접종시켜 1 내지 2일 배양한 후 생균수를 측정하였다.0.1 g of each extract was added to 10 milliliters of Brain Heart Infusion (BHI), and then inoculated with strains cultured for 1 to 2 days, followed by 1 to 2 days of culture, and the number of viable cells was measured.
실험결과Experiment result
살균력 실험결과 금초, 마로니에 등의 식물 추출물이 유의한 효과를 나타내었다.As a result of bactericidal activity, plant extracts such as marigold and horse chestnut showed significant effects.
주) 살균력 판정기준Note) Sterilization power criteria
◎ : 생균수 1.0×105이하◎: Viable cell count 1.0 × 10 5 or less
○ : 생균수 1.0×106이하 내지 1.0×105이상○: Number of viable cells 1.0 × 10 6 or less to 1.0 × 10 5 or more
X : 생균수 1.0×107이상X: Number of viable cells 1.0 × 10 7 or more
대조균 : 생균수 1.0×108이하Control bacteria: Number of live bacteria 1.0 × 10 8 or less
실시예 1 내지 2Examples 1-2
구강위생 증진용 조성물 중 치약 조성물의 제조 순서는 습윤성분인 비결정성 솔비톨액에 카르복시 메틸셀룰로오스 나트륨, 삭카린, 방부제 등 분말 소량 성분을 분산시키고, 정제수로 묽힌 다음 혼합기에서 1차 혼합하고, 그 다음에 인산일 소칼슘 등의 연마제를 혼합했다. 그리고 마지막으로 기포제인 알킬 황산나트륨, 안정제류, 향료 성분을 넣고 진공상태하에서 3차 혼합함으로써 치약조성물을 제조하였다. 기타의 구강 위생 중진용 조성물의 제조는 통상적인 제조순서에 따라 제조하였다.Toothpaste composition of the composition for oral hygiene is prepared by dispersing a small amount of carboxy methyl cellulose sodium, saccharin, preservatives and the like in a wet crystalline sorbitol liquid, diluted with purified water, and then mixed first in a mixer, and then Abrasives, such as monocalcium phosphate, were mixed with it. And finally, the toothpaste composition was prepared by adding a foaming agent sodium sodium sulfate, stabilizers, flavoring ingredients and tertiary mixing under vacuum. The preparation of other oral hygiene neutralizing compositions was made according to a conventional manufacturing procedure.
실시예 1 내지 2와 비교예 1 내지 3치약의 치태생성 억제효과, 치은 염증 완화효과 비교실험Example 1 to 2 and Comparative Examples 1 to 3 toothpaste inhibitory effect, gingival inflammation alleviating effect comparison experiment
실혐예 2Example 2
표 2의 실시예 1 내지 2와 비교예 1 내지 3의 치약을 사용하여 치태 형성억제 작용을 시험하였다.Inhibition of plaque formation was tested using the toothpastes of Examples 1 to 2 and Comparative Examples 1 to 3 of Table 2.
실험균주Experimental strain
스트렙토 코카즈 뮤탄즈(S. mutans 104449, 혈청형 C)Streptococcus mutans (S. mutans 104449, serotype C)
실험방법Experiment method
가. 실험균주를 BHI(Brain Heart Infusion agar)에서 배양하고 이균을 백금이로 THB(Todd Hewit Broth)에 접종하여 37℃에서 15 내지 16시간동안 배양한다.end. The experimental strains were incubated in Brain Heart Infusion agar (BHI), and the bacteria were inoculated in THB (Todd Hewit Broth) with platinum and incubated at 37 ° C. for 15-16 hours.
나. 치태형성 억제시험을 위하여 직경 2㎜, 길이 7㎝의 유리봉을 준비하여 180℃에서 2시간 동안 건조기에서 멸균시킨 후 무게를 측정한다.I. For the plaque formation inhibition test, a glass rod having a diameter of 2 mm and a length of 7 cm is prepared, sterilized in a dryer at 180 ° C. for 2 hours, and weighed.
다. 유리봉을 1% 슈크로즈(w/v)를 포함하는 THB가 들어있는 시험관에 넣고 실시예 및 비교예 치약의 시험용액을 일정한 농도 첨가한 후 스트렙 코카즈 뮤탄즈 0.1㎜를 첨가하여 37℃에서 24시간 배양한다.All. The glass rod was placed in a test tube containing THB containing 1% sucrose (w / v), and a test solution of the toothpaste of Examples and Comparative Examples was added at a constant concentration. Then, 0.1 mm of Strep Coca's Mutans was added thereto at 37 ° C. Incubate for 24 hours.
라. 배양후 유리봉을 조심스럽게 들어내어 37℃에서 하루동안 건조시킨 후 최종무게를 측정한다. 대조군은 시험용액을 첨가하지 않은 시험군으로 한다.la. After incubation, carefully lift the glass rod and dry it at 37 ° C for one day, and then measure the final weight. The control group is the test group without the test solution.
* 치약의 시험용액 제조 : 각 치약의 50중량% 용액을 만들어 불용분을 원심분리시켜 제거한후 여백을 시험용액으로 한다.* Preparation of Toothpaste Test Solution: Make a 50% by weight solution of each toothpaste, remove insolubles by centrifugation, and use the blank as a test solution.
실험결과Experiment result
표 3의 결과는 실시예 1 내지 2와 비교예 2가 치태형성 억제 효과가 있음을 나타낸다.The results in Table 3 show that Examples 1 and 2 and Comparative Example 2 have the effect of inhibiting plaque formation.
실험예 3Experimental Example 3
표 2의 실시예 1 내지 2와 비교예 1 내지 3의 치약을 사용하여 치은 염증 완화효과를 비교 시험하였다.Example 1 to 2 of Table 2 and the toothpaste of Comparative Examples 1 to 3 were used to compare the gingival inflammation relieving effect.
본 발명치약과 비교예 치약을 가지고 매일 3회씩(각 3분간) 20일간 양치질하게 하고 잇몸의 색상변화를 측정하여 잇몸의 건강상태 유지 및 개선효과를 비교시험 하였다. 색상변화는 일본전색의 I 80 색차계를 사용하였다The toothpaste of the present invention and the comparative example toothpaste was brushed three times daily (for 3 minutes each) for 20 days and the color change of the gum was measured to compare and maintain the health condition and improvement effect of the gums. For color change, I80 color difference meter was used.
통상 건강한 잇몸일수록 명도지수가 크고, 적색도가 높으며, 황색도는 낮게 나타난다. 즉 선명한 홍색을 나타내게 된다.Normally, healthy gums have a higher brightness index, higher redness, and lower yellowness. That is, a bright red color will appear.
실험결과Experiment result
실시예 1 내지 2와 비교예 2는 비교예 1과 3에 비하여 선명한 홍색을 나타내므로 치은 염증 완화작용이 우수함을 나타내며, 비교예 2는 치은 염증 완화작용은 우수하나 치약에 함유된 식물 추출물의 독특한 맛 때문에 치약사용감이 불량하였다.Examples 1 to 2 and Comparative Example 2 shows a clear red color compared to Comparative Examples 1 and 3 shows excellent gingival inflammation alleviating effect, Comparative Example 2 has excellent gingival inflammation alleviating effect but unique to plant extracts contained in toothpaste The toothpaste feeling was poor because of the taste.
실시예 3 : 구강청정제Example 3: Mouthwash
에탄올(90%)20.0%Ethanol (90%) 20.0%
글리세린(98%)10.0%Glycerin (98%) 10.0%
폴리옥시에틸렌Polyoxyethylene
폴리옥시프로필렌 공중합체1.0%Polyoxypropylene Copolymer 1.0%
금초(Yarrow) 엑기스0.1%Yarrow Extract 0.1%
삭카린 나트륨0.1%Zaccarin Sodium0.1%
향 료1.0%Fragrance1.0%
정제수 가하여100.0%Purified water add 100.0%
실시예 4 : 의치세정제(정제)Example 4 Denture Cleaner (Tablet)
탄산수소나트륨30.0%Sodium bicarbonate 30.0%
주석산27.0%Tartaric acid27.0%
코코일사르코신산나트륨5.0%Sodium Cocoyl Sarcosate 5.0%
라우릴 황산나트륨5.0%Sodium Lauryl Sulfate5.0%
염화 벤잘코니움2.0%Benzalkonium Chloride2.0%
EDTA 나트륨5.0%EDTA Sodium5.0%
트리폴리인산나트륨14.0%Sodium tripolyphosphate14.0%
폴리에틸렌글리콜2.0%Polyethylene Glycol2.0%
금초(Yarrow) 엑기스0.2%Yarrow Extract 0.2%
마로니에(Horse Chestnut)엑기스0.2%Horse Chestnut Extract 0.2%
향 료적 량Perfumery
실시예 5Example 5
껌베이스25.0%Gum base 25.0%
솔비톨44.0%Sorbitol44.0%
만니톨12.0%Mannitol 12.0%
글리세린13.0%Glycerin13.0%
렉시딘0.5%Lexidine0.5%
감미제2.0%Sweetener 2.0%
금초(Yarrow)엑기스0.1%Yarrow Extract 0.1%
향료적 량Fragrance
실시예 1 내지 5는 공히 치주질환 예방, 치료 및 충치예방에 우수한 효과가 있었다.Examples 1 to 5 all had excellent effects on preventing, treating and preventing tooth decay.
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1019920018403A KR0138248B1 (en) | 1992-10-07 | 1992-10-07 | The oral cavity hygienic compositions |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1019920018403A KR0138248B1 (en) | 1992-10-07 | 1992-10-07 | The oral cavity hygienic compositions |
Publications (2)
Publication Number | Publication Date |
---|---|
KR940008668A KR940008668A (en) | 1994-05-16 |
KR0138248B1 true KR0138248B1 (en) | 1998-05-15 |
Family
ID=19340765
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019920018403A KR0138248B1 (en) | 1992-10-07 | 1992-10-07 | The oral cavity hygienic compositions |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR0138248B1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006106994A1 (en) * | 2005-03-31 | 2006-10-12 | Kobayashi Pharmaceutical Co., Ltd. | Drug for periodontal disease comprising component extracted from aesculus hippocastanum l. |
US9962331B2 (en) * | 2001-10-26 | 2018-05-08 | Angiolab, Inc. | Composition containing horse chestnut extract |
-
1992
- 1992-10-07 KR KR1019920018403A patent/KR0138248B1/en not_active IP Right Cessation
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9962331B2 (en) * | 2001-10-26 | 2018-05-08 | Angiolab, Inc. | Composition containing horse chestnut extract |
WO2006106994A1 (en) * | 2005-03-31 | 2006-10-12 | Kobayashi Pharmaceutical Co., Ltd. | Drug for periodontal disease comprising component extracted from aesculus hippocastanum l. |
Also Published As
Publication number | Publication date |
---|---|
KR940008668A (en) | 1994-05-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR20180081032A (en) | Composition for prevention or treatment of oral disease comprising Pueraria Extract | |
KR101881636B1 (en) | Composition for prevention or treatment of oral disease comprising Pueraria Extract | |
KR102509579B1 (en) | Oral composition comprising cassava extract | |
KR102562835B1 (en) | Composition for prevention or treatment of oral disease comprising ROSAE LAEVIGATAE Extract | |
CN107260792B (en) | Composition for preventing or treating oral diseases comprising natural complex | |
KR0138248B1 (en) | The oral cavity hygienic compositions | |
KR102597684B1 (en) | Oral composition comprising amaranth extract | |
KR980008210A (en) | Composition for promoting oral hygiene | |
KR0121550B1 (en) | Tooth dentifrice composition | |
KR20180047704A (en) | Composition for prevention or treatment of oral disease comprising Scutellaria baicalensis extract | |
KR0149483B1 (en) | Antiplague compositions | |
KR20170142740A (en) | Composition for treating or preventing oral diseases comprising natural complex | |
KR102548925B1 (en) | Composition for prevention or treatment of oral disease comprising Scopoletin | |
KR102415612B1 (en) | Composition for prevention or treatment of oral disease comprising Melonis Pedicellus Extract | |
KR20020082308A (en) | Composition for the mouth containing extraction of Euonymus alatus Sieb | |
KR20170103482A (en) | Composition for prevention or treatment of oral disease comprising Glechoma hederacea extract | |
KR20170037231A (en) | Oral composition comprising purslane extract | |
KR101818211B1 (en) | Composition for prevention or treatment of oral disease comprising Arctill fructus Extract | |
KR20180047703A (en) | Composition for prevention or treatment of oral disease comprising Nelumbo Nucifera extract | |
DE68914451T2 (en) | ORAL SUPPLIES. | |
KR102541843B1 (en) | Composition for prevention or treatment of oral disease comprising Arctiin | |
KR102597685B1 (en) | Oral composition comprising parsley extract | |
KR102564564B1 (en) | Composition for prevention or treatment of oral disease comprising 2-methoxycinnamaldehyde | |
KR102562830B1 (en) | Composition for prevention or treatment of oral disease comprising Kochiae Fructus Extract | |
KR102379228B1 (en) | Oral composition comprising chives extract |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20101222 Year of fee payment: 14 |
|
LAPS | Lapse due to unpaid annual fee |